Key Quantitative Figures

  • IPO Date: September 9, 2025 (Date of Listing)
  • Amount Raised: ₹126 crore
  • Reporting Quarter: Ended September 30, 2026
  • Funds Utilized as of September 30, 2026:
  • SteriPort manufacturing line: ₹6,701.81 lakh out of ₹7,000.00 lakh allocated
  • SVP manufacturing line: ₹793.99 lakh out of ₹3,013.11 lakh allocated
  • General corporate purposes: ₹302.08 lakh out of ₹660.46 lakh allocated (modified from original)
  • Issue expenses: ₹2,284.81 lakh out of ₹1,926.43 lakh allocated (modified from original)

Parties Involved

  • Listed Entity: Amanta Healthcare Limited (CIN: L24139GJ1994PLC023944)
  • Monitoring Agency: CRISIL Ratings Limited
  • Stock Exchanges: BSE Limited (Scrip Code: 544502) and National Stock Exchange of India Limited (Trading Symbol: AMANTA)
  • Signatories:
  • Dinodia Nikhita, Company Secretary & Compliance Officer
  • Paras Mehta, Chief Financial Officer

Financial Impact

No deviation or variation in use of IPO proceeds confirmed. All funds utilized according to original objects with following historical modification:

In quarter ended September 30, 2025, issue expenses were modified to account for GST payment made over the cost as per the Offer Document. Consequently:

  • Issue expenses increased from ₹1,926.43 lakh to ₹2,284.81 lakh
  • General corporate purpose expenses decreased from ₹660.46 lakh to ₹302.08 lakh

This modification was previously disclosed and does not constitute a current quarter deviation.

Capital Structure Impact

No impact on capital structure disclosed. The disclosure solely concerns utilization of previously raised funds.

Monitoring & Review

  • Audit Committee reviewed and approved the statement at meeting held on November 3, 2026
  • No comments from Audit Committee
  • No comments from auditors
  • Monitoring agency CRISIL Ratings Limited confirmed applicable

Objects of Fund Utilization

1. Funding capital expenditure for civil construction and equipment for SteriPort manufacturing line at Hariyala, Kheda, Gujarat

2. Funding capital expenditure for civil construction and equipment for SVP manufacturing line at Hariyala, Kheda, Gujarat

3. General corporate purposes

4. Issue expenses